Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2-negative breast cancer.

ABSTRACT:

SUBMITTER: Bertucci F 

PROVIDER: S-EPMC10397558 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature